Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8 (OPD) (TP Group plc)

10 Nov 2022 07:00

RNS Number : 8827F
TP Group PLC
10 November 2022
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

TP Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

9 November 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Β 

N/A

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary shares of 1p each in the capital of TP Group plc

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Β 

Nil

Β 

(2) Cash-settled derivatives:

Β 

Nil

Β 

Nil

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Β 

Nil

Β 

Β 

TOTAL:

Nil

Β 

Nil

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

a) Ordinary Shares of 1p each in the capital of TP Group plc held by Directors of TP Group plc and their close relatives:

Β 

Name

No. of Shares

% of Issued Share Capital

David Lindsay (Non-Executive Director)

2,600,000

0.33%

Derren Stroud (Chief Financial Officer)

653,847

0.08%

Β 

Β 

b) Options and awards granted under TP Group's share option scheme held by the directors of TP Group plc.

Β 

No directors of TP Group plc hold any options over ordinary shares in TP Group plc, nor any other rights to subscribe for new ordinary shares.

Β 

c) Interests or rights to subscribe held by connected advisers of TP Group plc

Β 

Cenkos Securities plc holds warrants to subscribe for new ordinary shares in TP Group plc:

Β 

Name

Β 

Warrant holder

Description of warrants

Number of warrants over new ordinary shares

Grant date

Lapse date

Exercise price

Cenkos Securities plc

Warrants to subscribe for new ordinary shares in TP Group plc

23,375,361

29 September 2021

29 September 2026

5.8p per share

Β 

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

10 November 2022

Contact name:

Derren Stroud, Chief Financial Officer and Company Secretary

Β 

Telephone number:

Tel: 01753 285802

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEEEAKFNEFXAFFA
Date   Source Headline
24th Sep 20183:37 pmRNSForm 8.3 - Science Group PLC
24th Sep 20181:50 pmRNSForm 8.3 - Science Group Plc
24th Sep 20181:18 pmRNSForm 8.3 - Science Group Plc
24th Sep 20188:10 amRNSForm 8.5 (EPT/RI) - Science Group PLC
21st Sep 20182:32 pmRNSForm 8.3 - Unicorn Asset Management
21st Sep 20187:01 amRNSFormal Sale Process as Part of Strategic Review
21st Sep 20187:00 amRNSCorporate Strategic Review
5th Sep 20187:00 amRNSTreasury shares issued
26th Jul 201812:00 pmRNSTR1: Notification of Major Interest in Shares
24th Jul 20187:00 amRNSInterim Results
18th Jul 20187:00 amRNSNotice of Interim Results
15th May 20187:00 amRNSIssue of share options & PDMR dealing
14th May 20187:00 amRNSTreasury shares issued
25th Apr 20187:00 amRNSTreasury shares issued
19th Apr 201812:00 pmRNSResult of AGM
19th Apr 20187:01 amRNSAGM Business Update and Share Buy-Back Programme
19th Apr 20187:00 amRNSNominated Advisor and Broker
29th Mar 20187:00 amRNSTreasury shares issued
26th Mar 20187:00 amRNSFreehold Property Valuations
23rd Mar 20187:00 amRNSPosting of documents to shareholders & AGM notice
23rd Mar 20187:00 amRNSTSG Consideration
20th Mar 20187:01 amRNSTransaction in Own Shares
20th Mar 20187:00 amRNSTreasury shares issued
19th Mar 20187:00 amRNSTransaction in Own Shares
16th Mar 20187:00 amRNSTransaction in Own Shares
15th Mar 20187:00 amRNSTR1: Notification of Major Interest in Shares
15th Mar 20187:00 amRNSTreasury shares issued & PDMR dealing(Replacement)
14th Mar 20187:00 amRNSTreasury shares issued & PDMR dealing
28th Feb 20187:00 amRNSAudited results for year ended 31 December 2017
22nd Feb 20183:16 pmRNSNotice of Preliminary Results
4th Jan 20187:00 amRNSTR1: Notification of Major Interest in Shares
20th Dec 20177:00 amRNSTR1: Notification of Major Interest in Shares
6th Dec 20177:00 amRNSTR1 Notification of Major Interest in Shares
18th Oct 20177:00 amRNSTreasury shares issued
21st Sep 20177:00 amRNSTR-1: Notification of Major Interest in Shares
7th Sep 20177:00 amRNSIssue of Share Options and PDMR Dealing
6th Sep 20177:00 amRNSAcquisition of Technology Sciences Group
4th Sep 20177:00 amRNSAcquisition of Technology Sciences Group
1st Aug 20172:00 pmRNSTR-1: Notification of Major Interest in Shares
31st Jul 20174:20 pmRNSTR-1: Notification of Major Interest in Shares
28th Jul 201710:40 amRNSTR-1: Notification of Major Interest in Shares
25th Jul 20177:00 amRNSInterim Results
20th Jul 20175:29 pmRNSNotice of Interim Results (Replacement)
20th Jul 20173:15 pmRNSNotice of Interim Results
18th May 201710:15 amRNSResult of AGM
15th May 20177:00 amRNSTreasury shares issued
21st Apr 20177:00 amRNSPosting of Documents and Notice of AGM
4th Apr 20177:00 amRNSTreasury shares issued
31st Mar 20173:19 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSTreasury shares issued

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.